243 related articles for article (PubMed ID: 26497850)
1. Increased tumor infiltration by mucosal-associated invariant T cells correlates with poor survival in colorectal cancer patients.
Zabijak L; Attencourt C; Guignant C; Chatelain D; Marcelo P; Marolleau JP; Treiner E
Cancer Immunol Immunother; 2015 Dec; 64(12):1601-8. PubMed ID: 26497850
[TBL] [Abstract][Full Text] [Related]
2. Invariant Valpha7.2-Jalpha33 TCR is expressed in human kidney and brain tumors indicating infiltration by mucosal-associated invariant T (MAIT) cells.
Peterfalvi A; Gomori E; Magyarlaki T; Pal J; Banati M; Javorhazy A; Szekeres-Bartho J; Szereday L; Illes Z
Int Immunol; 2008 Dec; 20(12):1517-25. PubMed ID: 18927318
[TBL] [Abstract][Full Text] [Related]
3. Mucosal-Associated Invariant T Cells Display Diminished Effector Capacity in Oesophageal Adenocarcinoma.
Melo AM; O'Brien AM; Phelan JJ; Kennedy SA; Wood NAW; Veerapen N; Besra GS; Clarke NE; Foley EK; Ravi A; MacCarthy F; O'Toole D; Ravi N; Reynolds JV; Conroy MJ; Hogan AE; O'Sullivan J; Dunne MR
Front Immunol; 2019; 10():1580. PubMed ID: 31354725
[TBL] [Abstract][Full Text] [Related]
4. Isolation and Characterization of MAIT Cells from Tumor Tissues.
Rodin W; Sundström P; Quiding Järbrink M
Methods Mol Biol; 2020; 2098():39-53. PubMed ID: 31792814
[TBL] [Abstract][Full Text] [Related]
5. Mucosa-associated invariant T cells infiltrate hepatic metastases in patients with colorectal carcinoma but are rendered dysfunctional within and adjacent to tumor microenvironment.
Shaler CR; Tun-Abraham ME; Skaro AI; Khazaie K; Corbett AJ; Mele T; Hernandez-Alejandro R; Haeryfar SMM
Cancer Immunol Immunother; 2017 Dec; 66(12):1563-1575. PubMed ID: 28798979
[TBL] [Abstract][Full Text] [Related]
6. A Role for MAIT Cells in Colorectal Cancer.
Berzins SP; Wallace ME; Kannourakis G; Kelly J
Front Immunol; 2020; 11():949. PubMed ID: 32508830
[TBL] [Abstract][Full Text] [Related]
7. Lymphocytic infiltration in stage II microsatellite stable colorectal tumors: A retrospective prognosis biomarker analysis.
Sanz-Pamplona R; Melas M; Maoz A; Schmit SL; Rennert H; Lejbkowicz F; Greenson JK; Sanjuan X; Lopez-Zambrano M; Alonso MH; Qu C; McDonnell KJ; Idos GE; Vignali M; Emerson R; Fields P; Guinó E; Santos C; Salazar R; Robins HS; Rennert G; Gruber SB; Moreno V
PLoS Med; 2020 Sep; 17(9):e1003292. PubMed ID: 32970670
[TBL] [Abstract][Full Text] [Related]
8. Circulating and tumor-infiltrating mucosal associated invariant T (MAIT) cells in colorectal cancer patients.
Ling L; Lin Y; Zheng W; Hong S; Tang X; Zhao P; Li M; Ni J; Li C; Wang L; Jiang Y
Sci Rep; 2016 Feb; 6():20358. PubMed ID: 26837580
[TBL] [Abstract][Full Text] [Related]
9. Clinical relevance of circulating mucosal-associated invariant T cell levels and their anti-cancer activity in patients with mucosal-associated cancer.
Won EJ; Ju JK; Cho YN; Jin HM; Park KJ; Kim TJ; Kwon YS; Kee HJ; Kim JC; Kee SJ; Park YW
Oncotarget; 2016 Nov; 7(46):76274-76290. PubMed ID: 27517754
[TBL] [Abstract][Full Text] [Related]
10. Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer.
Tosolini M; Kirilovsky A; Mlecnik B; Fredriksen T; Mauger S; Bindea G; Berger A; Bruneval P; Fridman WH; Pagès F; Galon J
Cancer Res; 2011 Feb; 71(4):1263-71. PubMed ID: 21303976
[TBL] [Abstract][Full Text] [Related]
11. Human Tumor-Infiltrating MAIT Cells Display Hallmarks of Bacterial Antigen Recognition in Colorectal Cancer.
Li S; Simoni Y; Becht E; Loh CY; Li N; Lachance D; Koo SL; Lim TP; Tan EKW; Mathew R; Nguyen A; Golovato J; Berkson JD; Prlic M; Lee B; Minot SS; Nagarajan N; Dey N; Tan DSW; Tan IB; Newell EW
Cell Rep Med; 2020 Jun; 1(3):100039. PubMed ID: 33205061
[TBL] [Abstract][Full Text] [Related]
12. Investigation of the prognostic value of CD4 T cell subsets expanded from tumor-infiltrating lymphocytes of colorectal cancer liver metastases.
Kroemer M; Turco C; Spehner L; Viot J; Idirène I; Bouard A; Renaude E; Deschamps M; Godet Y; Adotévi O; Limat S; Heyd B; Jary M; Loyon R; Borg C
J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33229508
[TBL] [Abstract][Full Text] [Related]
13. Exhaustion in tumor-infiltrating Mucosal-Associated Invariant T (MAIT) cells from colon cancer patients.
Rodin W; Sundström P; Ahlmanner F; Szeponik L; Zajt KK; Wettergren Y; Bexe Lindskog E; Quiding Järbrink M
Cancer Immunol Immunother; 2021 Dec; 70(12):3461-3475. PubMed ID: 33885944
[TBL] [Abstract][Full Text] [Related]
14. Mucosal-Associated Invariant T Cells in Tumors of Epithelial Origin.
Zumwalde NA; Gumperz JE
Adv Exp Med Biol; 2020; 1224():63-77. PubMed ID: 32036605
[TBL] [Abstract][Full Text] [Related]
15. Dual role of tumour-infiltrating T helper 17 cells in human colorectal cancer.
Amicarella F; Muraro MG; Hirt C; Cremonesi E; Padovan E; Mele V; Governa V; Han J; Huber X; Droeser RA; Zuber M; Adamina M; Bolli M; Rosso R; Lugli A; Zlobec I; Terracciano L; Tornillo L; Zajac P; Eppenberger-Castori S; Trapani F; Oertli D; Iezzi G
Gut; 2017 Apr; 66(4):692-704. PubMed ID: 26719303
[TBL] [Abstract][Full Text] [Related]
16. Mucosa-associated invariant T cells in malignancies: a faithful friend or formidable foe?
Haeryfar SMM; Shaler CR; Rudak PT
Cancer Immunol Immunother; 2018 Dec; 67(12):1885-1896. PubMed ID: 29470597
[TBL] [Abstract][Full Text] [Related]
17. Targeting mitochondrial dysfunction in MAIT cells: Potential immunotherapeutic treatment for colorectal cancer.
Lin D; Zhong S; Liu J
Med Hypotheses; 2021 Jan; 146():110358. PubMed ID: 33317849
[TBL] [Abstract][Full Text] [Related]
18. Circulating mucosal-associated invariant T cell levels and their cytokine levels in healthy adults.
Lee OJ; Cho YN; Kee SJ; Kim MJ; Jin HM; Lee SJ; Park KJ; Kim TJ; Lee SS; Kwon YS; Kim N; Shin MG; Shin JH; Suh SP; Ryang DW; Park YW
Exp Gerontol; 2014 Jan; 49():47-54. PubMed ID: 24269212
[TBL] [Abstract][Full Text] [Related]
19. Image analyzer-based assessment of tumor-infiltrating T cell subsets and their prognostic values in colorectal carcinomas.
Kim Y; Bae JM; Li G; Cho NY; Kang GH
PLoS One; 2015; 10(4):e0122183. PubMed ID: 25875774
[TBL] [Abstract][Full Text] [Related]
20. Two FOXP3(+)CD4(+) T cell subpopulations distinctly control the prognosis of colorectal cancers.
Saito T; Nishikawa H; Wada H; Nagano Y; Sugiyama D; Atarashi K; Maeda Y; Hamaguchi M; Ohkura N; Sato E; Nagase H; Nishimura J; Yamamoto H; Takiguchi S; Tanoue T; Suda W; Morita H; Hattori M; Honda K; Mori M; Doki Y; Sakaguchi S
Nat Med; 2016 Jun; 22(6):679-84. PubMed ID: 27111280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
